Embedded Files
Here we describe what we do and why it matters, using plain English and minimal jargon.
Psychedelics change how brain networks talk to each other
For decades, brain imaging studies of psychedelic drugs such as psilocybin, LSD and ayahuasca have produced a complicated picture. Some suggested that psychedelics disintegrate brain networks; others claimed they make the brain more chaotic, or more flexible, or less constrained by top‑down control. A new international study, published in Nature Medicine, provides the clearest answer so far to what psychedelics consistently do to the human brain. By pooling brain‑scanning data from five different psychedelic drugs (psilocybin, lysergic acid diethylamide, mescaline, N,N-dimethyltryptamine and ayahuasca), we identified a shared, reproducible pattern of brain reorganisation that appears across substances, sites and participants.
The findings suggest that psychedelics do not simply shut down or fragment brain networks. Instead, they fundamentally reconfigure how large‑scale brain systems interact, increasing communication between networks that are usually kept separate, while modestly weakening connections within individual networks.
Unifying disparate findings
Neuroimaging (MRI, EEG, MEG) studies of psychedelics face substantial practical challenges. Psychedelic experiments are expensive, highly regulated and typically involve small samples, often fewer than 20 participants. Different labs also use different data processing pipelines and statistical models, making it hard to compare results directly. As a result, the literature grew somewhat fragmented. Some influential studies suggested that the brain’s default mode network, a system linked to introspection and self‑related thought, disintegrates under psychedelics. Others reported increases in network integration instead. Still others observed changes in sensory or motor circuits. The new study tackled this problem by using a mega‑analysis approach (combining raw data) from 11 independent datasets, spanning psilocybin, LSD, mescaline, DMT and ayahuasca, with over 500 scans from 267 participants. Crucially, all data were processed using the same pipeline and analysed using a Bayesian hierarchical framework, allowing us to distinguish robust effects from those that vary across drugs or study sites.
A shared brain signature across psychedelic drugs
Despite the chemical diversity of the drugs studied, we found a striking common pattern. Across substances, psychedelics increased communication between “transmodal” association networks (those involved in higher‑order cognition, such as the default mode and frontoparietal networks) and unimodal sensory and motor networks, including visual and somatomotor systems. Brain systems responsible for abstract thinking, planning and self‑reflection became therefore more tightly coupled with systems processing sensation and movement. This increased cross‑network crosstalk provides a plausible neural explanation for psychedelic experiences such as intensified sensory perception, vivid imagery, and the feeling that thoughts and perceptions are unusually interconnected. Importantly, this effect was not confined to the cortex. Our study also found altered coupling between cortical networks and subcortical regions, including the thalamus, caudate, putamen and cerebellum, structures crucial for coordinating perception, action and cognitive flow.
Rethinking brain network fragmentation
One of the most influential claims in psychedelic neuroscience has been that psychedelics cause brain networks to disintegrate. However, we added nuance to this idea by observing only some reductions in within‑network connectivity, meaning that individual networks became slightly less internally cohesive. These effects were weak to moderate, highly variable, and far from universal across drugs or regions. Rather than global disintegration, the dominant pattern was selective reweighting: networks retained their internal structure while becoming more prone to interaction with other systems. This distinction matters. A brain that merely disintegrates would be expected to show loss of function. Instead, people under psychedelics often report experiences that feel richly meaningful, emotionally intense and cognitively coherent, if somewhat unusual. The observed neural pattern supports increased integration, not chaos.
Relaxing top‑down control – but not losing it
The study’s findings align with theories suggesting that psychedelics relax the brain’s usual “top‑down” constraints, allowing information to flow more freely between levels of the processing hierarchy. Association (or high-order) networks normally exert strong control over sensory processing, filtering perception through expectations and prior beliefs, according to some theories. Under psychedelics, this control appears to loosen, enabling bottom‑up sensory signals to exert a stronger influence on thought and awareness. Crucially, the data show that this is not an all‑or‑nothing situation. Control systems remain active, but their dominance is softened, allowing alternative modes of integration to emerge. This may help explain why psychedelic experiences can feel simultaneously insightful and destabilising, offering new perspectives without completely abolishing cognitive structure.
Why this matters for mental health research
Interest in psychedelics as potential treatments for depression, anxiety, post-traumatic stress disorder and addiction has surged in recent years and clinical progress depends on understanding how these substances affect the brain. The mega‑analysis provides a probabilistic map of psychedelic brain action, a benchmark against which future studies can be compared. By resolving inconsistencies in earlier work, our findings offer a firmer foundation for comparing different psychedelic compounds, linking brain changes to therapeutic outcomes, and designing interventions that target specific network interactions rather than entire systems. They also underscore the importance of moving beyond single‑network explanations and towards a systems‑level understanding of mental health.
A new phase for psychedelic neuroscience
By demonstrating that reliable, cross‑drug patterns can be identified despite existing fragmented findings, we signal a maturation of psychedelic neuroscience. The message is clear: psychedelics do not simply disrupt the brain. They reorganise its large‑scale architecture, increasing dialogue between systems that rarely interact, an effect that may underlie both their profound subjective impact and their emerging therapeutic promise. Future work will need to test how these network changes relate to clinical response and long‑term outcomes. But for now, the picture is sharper than ever: psychedelics connect the brain in new ways, rather than breaking it apart.
Page updated
Google Sites
Report abuse